Bioequivalency studies
Ended Awarded Last action
- Contract number
- HHSN26100024
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $376,353
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $376,353.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost No Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,578 | |
| Funding Only Action | -$2,753 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $1,578 | |
| Other Administrative Action | $0 | |
| Original award | $379,106 |
About this award
This is a $376,353.24 federal contract award issued by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for "BIOEQUIVALENCY STUDIES" and was awarded on September 2, 2016, with a period of performance through March 1, 2019.
Leidos Biomedical Research Inc. serves as a Federally Funded Research and Development Center (FFRDC) contractor for the NCI, providing a range of biomedical research and facilities support services. This contract award does not have a set-aside designation. The parent company, Leidos Holdings, has acted as a subcontractor on various prior federal contracts, though it does not appear to have any prime federal contract awards based on the information provided.
Quick answers
Who was awarded contract HHSN26100024?
HHSN26100024 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 2, 2016.
How much is contract HHSN26100024 worth?
The government has obligated $376,353 on HHSN26100024.
Is contract HHSN26100024 an order under another contract?
Yes. HHSN26100024 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100024 competed?
The extent of competition for HHSN26100024 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award